Moderna hits 52-week high on strong Q3 results
MRNA Moderna Inc
$250.83 -6.75%
View chart & analysis → - 1Moderna shares rose 10% during Friday's trading session to reach a 52-week high of $267 per share.
- 2Moderna's Q3 earnings per share of $0.38 beat expectations by 134%.
- 3Moderna raised its full-year 2026 revenue growth outlook to 15% to 25%.
So what's the key point?
Moderna's stock price rose to $267 because the company earned much more money than experts expected. The stock is gaining momentum as future revenue is also expected to increase.
Source Zacks +1 · View original ↗
Nothing hidden: past picks and how they did against the S&P 500.